Showing results (21-30 of 260) with videos related to
Sort By:
Pageof 26
Oncology (Williston Park, N.Y.)|May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New DirectionsPatrick M Reagan, Jonathan W FriedbergJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young AdultsKara M Kelly, Jonathan W FriedbergCurrent Oncology Reports|August 19, 2008
Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphomaManzurul A Sikder, Jonathan W FriedbergThe Oncologist|April 4, 2009
Salvage therapy in Hodgkin's lymphomaJason H Mendler, Jonathan W FriedbergCurrent Hematologic Malignancy Reports|May 4, 2010
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?David W Dougherty, Jonathan W FriedbergSeminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W FriedbergFuture Oncology (London, England)|May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphomaPatrick M Reagan, Jonathan W FriedbergCurrent Treatment Options in Oncology|June 3, 2015
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphomaPatrick M Reagan, Jonathan W FriedbergOncogene|February 20, 2004
Gene expression profiling of ErbB receptor and ligand-dependent transcriptionDhara N Amin, Archibald S Perkins, David F SternBlood|December 16, 2014
Transformed follicular non-Hodgkin lymphomaCarla Casulo, W Richard Burack, Jonathan W FriedbergPageof 26